Dr. Mark Bennett Feinberg, M.D., Ph.D. (born 1956)

Wikipedia 🌐 NONE

Herbert A. Feinberg (dad) had given 1M+ to univ. Pittsburgh

https://www.giveto.pitt.edu/s/1729/18/interior-giving.aspx?sid=1729&gid=2&pgid=5061


mentioned in - 

Heinz Feldmann

obviously - IAVI ...

CEPI


2005 - co-authoring with Ira Longini..

https://pubmed.ncbi.nlm.nih.gov/16018721/ 

Epub 2005 Jul 19.

Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges

Roland R Regoes 1, Ira M Longini, Mark B Feinberg, Silvija I Staprans

Cell

. 2015 Jan 15;160(1-2):20-35. doi: 10.1016/j.cell.2014.12.003. Epub 2014 Dec 18.

Reservoir host immune responses to emerging zoonotic viruses

Judith N Mandl 1, Rafi Ahmed 2, Luis B Barreiro 3, Peter Daszak 4, Jonathan H Epstein 4, Herbert W Virgin 5, Mark B Feinberg 6

mother's wedding

https://www.newspapers.com/image/524640795/?terms=%22esther%20saroff%22&match=1 

Father : Herbert A. Feinberg

also

https://www.newspapers.com/image/149703037/?terms=%22esther%20saroff%22&match=1

1946-04-07-pittsburgh-sun-telegraph-pg-2-7

1946-04-07-pittsburgh-sun-telegraph-pg-2-7-clip-saroff-feinberg-engagement

1972 - Brother Richard Feinberg passes

https://www.newspapers.com/image/89545676/?terms=%22Herbert%20A.%20Feinberg%22&match=1

1972-07-21-the-pittsburgh-post-gazette-pg-27.jpg

1972-07-21-the-pittsburgh-post-gazette-pg-27-clip-richard-feinberg.jpg

https://www.geni.com/people/Esther-Feinberg/6000000000377483117


UNCLE

Meyer "mike" feinberg

https://www.legacy.com/us/obituaries/legacyremembers/meyer-feinberg-obituary?id=25710886



Middle initial - "B" ... 

https://www.science.org/doi/10.1126/science.aaq0215

Mark B. Feinberg

International AIDS Vaccine Initiative, New York, NY, USA.




https://www.ncbi.nlm.nih.gov/books/NBK62494/

Mark B. Feinberg, M.D., Ph.D.,1 is vice president for medical affairs and policy in global vaccine and infectious diseases at Merck & Co., Inc., and is responsible for global efforts to implement vaccines to achieve the greatest health benefits, including efforts to expand access to new vaccines in the developing world. Dr. Feinberg received a bachelor's degree magna cum laude from the University of Pennsylvania in 1978 and his M.D. and Ph.D. degrees from Stanford University School of Medicine in 1987. His Ph.D. research at Stanford was supervised by Dr. Irving Weissman and included time spent studying the molecular biology of the human retroviruses—human T-cell lymphotrophic virus, type I (HTLV-I) and HIV—as a visiting scientist in the laboratory of Dr. Robert Gallo at the National Cancer Institute. 

From 1985 to 1986, Dr. Feinberg served as a project officer for the IOM Committee on a National Strategy for AIDS. After receiving his M.D. and Ph.D. degrees, Dr. Feinberg pursued postgraduate residency training in internal medicine at the Brigham and Women's Hospital of Harvard Medical School and postdoctoral fellowship research in the laboratory of Dr. David Baltimore at the Whitehead Institute for Biomedical Research. From 1991 to 1995, Dr. Feinberg was an assistant professor of medicine and microbiology and immunology at the University of California, San Francisco (UCSF), where he also served as an attending physician in the AIDS-oncology division and as director of the virology research laboratory at San Francisco General Hospital. From 1995 to 1997, Dr. Feinberg was a medical officer in the Office of AIDS Research in the Office of the Director of the NIH, the chair of the NIH Coordinating Committee on AIDS Etiology and Pathogenesis Research, and an attending physician at the NIH Clinical Center. During this period, he also served as Executive Secretary of the NIH Panel to Define Principles of Therapy of HIV Infection.

Prior to joining Merck in 2004, Dr. Feinberg served as Professor of Medicine and Microbiology and immunology at the Emory University School of Medicine, as an investigator at the Emory Vaccine Center, and as an attending physician at Grady Memorial Hospital. At UCSF and Emory, Dr. Feinberg and colleagues were engaged in the preclinical development and evaluation of novel vaccines for HIV and other infectious diseases and in basic research studies focused on revealing fundamental aspects of the pathogenesis of AIDS. Dr. Feinberg also founded and served as the medical director of the Hope Clinic of the Emory Vaccine Center—a clinical research facility devoted to the clinical evaluation of novel vaccines and to translational research studies of human immune system biology. In addition to his other professional roles, Dr. Feinberg has also served as a consultant to, and a member of, several IOM and NAS committees. Dr. Feinberg currently serves as a member of the National Vaccine Advisory Committee and is a member of the Board of Trustees of the National Foundation for Infectious Diseases. Dr. Feinberg has earned board certification in internal medicine; he is a fellow of the American College of Physicians, a member of the Association of American Physicians, and the recipient of an Elizabeth Glaser Scientist Award from the Pediatric AIDS Foundation and an Innovation in Clinical Research Award from the Doris Duke Charitable Foundation.

https://www.iavi.org/about/senior-leadership/mark-feinberg


Mark Feinberg

President and CEO

Mark Feinberg, M.D., Ph.D., is president and CEO of IAVI where he leads a global team working to advance the development of vaccines and other biomedical innovations to protect against infection with HIV, TB, and other infectious diseases that disproportionately impact low-income countries.

Prior to joining IAVI in late 2015, Feinberg served as chief public health and science officer with Merck Vaccines. In this role, he helped advance the development and global availability of vaccines against rotavirus, human papillomavirus, and other infectious diseases. He also led a range of research initiatives to address unmet health needs in low-income countries including the establishment of the MSD-Wellcome Trust Hilleman Laboratories and the coordination of a private-public partnership to expedite Ebola vaccine development. Previously, he spent more than 20 years exploring HIV/AIDS pathogenesis, treatment, and prevention research and the biology of emerging diseases in both academia and government.

Feinberg holds an M.D. and a Ph.D. from Stanford University, and B.A. degree from the University of Pennsylvania. He pursued post-graduate medical training in internal medicine at the Brigham and Women’s Hospital and postdoctoral fellowship training in the laboratory of Dr. David Baltimore at the Whitehead Institute. He has previously served as a faculty member at the University of California, San Francisco and the Emory University School of Medicine and as a medical officer in the Office of AIDS Research at the National Institutes of Health (NIH) and as a fellow in the Advanced Leadership Initiative at Harvard University.

Feinberg is a fellow of the American College of Physicians and a member of the Council on Foreign Relations and the Association of American Physicians. He served as the chair of the Interim Scientific Advisory Committee of the Collaboration for Epidemic Preparedness Innovations (CEPI) and currently serves as a member of the CEPI Joint Coordinating Group.



https://www.legacy.com/us/obituaries/legacyremembers/esther-feinberg-obituary?id=26543369

Esther Feinberg Obituary

FEINBERG
ESTHER S.
On Thursday, November 17, 2005. Beloved mother of Mark (Jacqueline Fine) Feinberg and the late Richard Feinberg; sister of Ann Pechersky and the late Nathan Saroff; also survived by other close family members and many dear friends. Graveside Services and Interment will be held on Sunday at 2 pm at Beth Shalom Cemetery. Contributions may be made to CARE, 151 Ellis Street, Atlanta, GA 30303. Arrangements entrusted to RALPH SCHUGAR CHAPEL, INC.
Send condolences at post-gazette.com/gb


DIRECTORY INFO

https://www.whitepages.com/name/Mark-Bennett-Feinberg/Philadelphia-PA/Pbyww5kdAPy

2023-06-17-whitepages-com-mark-bennett-feinberg-pbyww5kdapy.pdf